NCT03237780 2026-03-18
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
NYU Langone Health
City of Hope Medical Center
St. Jude Children's Research Hospital